Evaluation of the efficiency and safety of anaferon (pediatric formulation) in the treatment of chickenpox in children.

Bull Exp Biol Med

Department of Infection Diseases in Children, Department of Clinical Pharmacology, St. Petersburg State Pediatric Medical Academy, Children's Polyclinic No.71, St. Petersburg.

Published: August 2009

Addition of anaferon (pediatric formulation) to the therapy of chickenpox patients led to more rapid disappearance of the main symptoms and alleviated the course of the disease. The safety of the preparation is confirmed by the absence of undesirable events and stability of laboratory indexes against the background of therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10517-009-0698-5DOI Listing

Publication Analysis

Top Keywords

anaferon pediatric
8
pediatric formulation
8
evaluation efficiency
4
efficiency safety
4
safety anaferon
4
formulation treatment
4
treatment chickenpox
4
chickenpox children
4
children addition
4
addition anaferon
4

Similar Publications

Objective: To evaluate the efficacy of different methods of antivirus therapy of tick-borne encephalitis (TBE) in children in the acute period and during chronic infections.

Material And Methods: During 1 year, 130 children, aged 7-17 years, with TBEV received therapy in the acute period (an average in 3.5±1.

View Article and Find Full Text PDF

Anaferon and pediatric anaferon based on release-active antibodies to interferon-gamma (R-A antibodies to INF-gamma) proved to be efficient in the treatment of many viral infections. Immunomodulating (immunotropic) properties of the drugs were revealed in the preclinical studies at many Russian and foreign research medical institutions and are reviewed herein. Anaferon and pediatric anaferon stimulated the humoral and cellular immune responses and increased the neutrophil and macrophage activity.

View Article and Find Full Text PDF

Aim: To study efficacy of anaferon pediatric in mice infected by pandemic influenza virus A(H1N1/09)v.

Materials And Methods: Influenza virus strain A/California/07/2009 (H1N1)v was used. Three groups of BALB/c mice intranasally inoculated with influenza virus were studied.

View Article and Find Full Text PDF

Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).

Bull Exp Biol Med

October 2010

Vector Research Center of Virology and Biotechnology, Federal Service on Surveillance for Consumer Rights Protection and Human WellBeing, Kol'tsovo, Novosibirsk Region, Russia.

Article Synopsis
  • Anaferon, a pediatric formulation, showed antiviral effects in mice infected with the H1N1 virus, significantly reducing virus production in their lungs.
  • Anaferon was administered both therapeutically and prophylactically, leading to a 10-fold decrease in viral load compared to control mice.
  • Its effectiveness was comparable to Tamiflu when given before or after the infection.
View Article and Find Full Text PDF

Poetam and anaferon (pediatric formulation) administered in combination with iron preparation to patients with anemia induce pronounced positive shifts in metabolic and morphological status of mature erythrocytes: the number of sulfhydryl groups and lipoprotein complexes in cell membranes and dry weight of erythrocytes increased, while the number of forms at different stages of degeneration decreased.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!